Recombinant Comments : Analyzing the Public Response to Proposed rDna Products

dc.contributor.advisorTurner, Stephanie S.
dc.contributor.authorMabis, Matthew
dc.date.accessioned2011-11-01T16:13:57Z
dc.date.available2011-11-01T16:13:57Z
dc.date.issued2011-05
dc.descriptionColor poster with text, charts, and graphs.en
dc.description.abstractA significant issue in the public understanding of science is the way in which citizens use digital media to influence policy making on cutting-edge research and emerging technologies. This study examines the public comments on the Food and Drug Administration's proposed guidelines for ATryn, the first drug manufactured from nonbacterial recombinant DNA, that is, human-animal gene splicing.en
dc.description.sponsorshipUniversity of Wisconsin--Eau Claire Office of Research and Sponsored Programsen
dc.identifier.urihttp://digital.library.wisc.edu/1793/54803
dc.language.isoen_USen
dc.relation.ispartofseriesUSGZE AS589en
dc.subjectGenetic engineering--Moral and ethical aspectsen
dc.subjectScience and state--Citizen participationen
dc.subjectTechnology and state--Citizen participationen
dc.subjectPostersen
dc.titleRecombinant Comments : Analyzing the Public Response to Proposed rDna Productsen
dc.typePresentationen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
MabisSpr11.pdf
Size:
1.19 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.03 KB
Format:
Item-specific license agreed upon to submission
Description: